INS and Hyperglycemia: Therefore hyperglycemia/hyperlipidemia-induced islet IL-1 activity promotes cytokine/chemokine expression, leading to recruitment of innate inflammatory cells, which alter both functional β-cell mass and insulin sensitivity [1]–[4].